GLP-1 Medications
Semaglutide and tirzepatide
- What it is
- GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after eating. Semaglutide activates the GLP-1 receptor. Tirzepatide activates both the GLP-1 and GIP receptors.
- What it does
- Increases insulin release when blood sugar is high, slows stomach emptying, and reduces appetite. The result is lower blood sugar and meaningful weight loss.
- FDA status
- FDA-approved brand products include Wegovy® and Ozempic® (semaglutide) and Zepbound® and Mounjaro® (tirzepatide). Compounded versions are not FDA-approved. Not for anyone with a personal or family history of medullary thyroid cancer or MEN 2.











